NovoCure Limited
14.68USD
-0.4200 (-2.78%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NVCR.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.23▲ | -$0.33 | 1 | 0 |
| Next quarter | -$0.24▲ | -$0.32 | 5 | 1 |
| Current year | -$1.24▲ | -$1.59 | 1 | 0 |
| Next year | -$0.81▲ | -$1.19 | 1 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.33 | -$0.13 | +0.20 (+60.8%) |
| 2026-03-31 | -$0.51 | -$0.62 | -0.11 (-20.9%) |
| 2025-12-31 | -$0.41 | -$0.22 | +0.19 (+46.5%) |
| 2025-09-30 | -$0.42 | -$0.33 | +0.09 (+21.4%) |
123 ratings from 17 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Neutral | $18 $20 | Jul 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $46 $52 | Jul 23, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $48 $46 | Jun 18, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $13.5 $17 | May 4, 2026 |
| Evercore ISI Group | Maintained | Outperform | $16 $20 | May 1, 2026 |
| Wedbush | Reiterated | Neutral | $18 | Apr 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $47 $49 | Feb 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $39 $47 | Feb 12, 2026 |
| Wedbush | Reiterated | Neutral | $18 | Jan 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $42 $39 | Jan 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38 $42 | Oct 30, 2025 |
| JP Morgan | Maintained | Neutral | $25 $23 | Oct 27, 2025 |
| Wells Fargo | Downgraded from Overweight | Equal-Weight | $40 $14.5 | Jul 25, 2025 |
| Ladenburg Thalmann | Initiated | Buy | $30 | Jul 8, 2025 |
| Piper Sandler | Reiterated | Overweight | $34 | Jun 27, 2025 |
| Piper Sandler | Maintained | Overweight | $42 $34 | Apr 23, 2025 |
| Wedbush | Maintained | Neutral | $29 $27 | Apr 16, 2025 |
| JP Morgan | Maintained | Neutral | $29 $28 | Apr 10, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $38 | Jan 14, 2025 |
| Piper Sandler | Maintained | Overweight | $28 $42 | Dec 13, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30 $38 | Dec 3, 2024 |
| HC Wainwright & Co. | Reiterated | Buy | $30 $38 | Dec 2, 2024 |
| Evercore ISI Group | Upgraded from In-Line | Outperform | $18 $30 | Dec 2, 2024 |
| HC Wainwright & Co. | Reiterated | Buy | $30 | Nov 21, 2024 |
| HC Wainwright & Co. | Reiterated | Buy | $30 | Oct 31, 2024 |
99 filings from 18 insiders · 13 buy / 8 sell over 6m
Officers and directors of NVCR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BEN ARYE BARAKGeneral Counsel | Grant | 1.3k | $15.15 | $20k | Jun 30, 2026 |
| PURI MICHAL NATHOfficer | Grant | 1.9k | $15.15 | $29k | Jun 30, 2026 |
| DANZIGER ASAFDirector | Grant | 268 | $15.15 | $4k | Jun 30, 2026 |
| LEONARD FRANCIS XAVIER IIChief Executive Officer | Grant | 1.9k | $15.15 | $29k | Jun 30, 2026 |
| LEONARD FRANCIS XAVIER IIChief Executive Officer | Sell | 34.3k | $17.93 | $615k | Jun 4, 2026 |
| OCEAN ALLYSON JDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| STAFFORD KRISTINDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| HILLEMAN JERYL LDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| LEUNG KINYIP GABRIELDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| HUNG DAVID TDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| VERNON WILLIAM ANTHONYDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| SCANNELL TIMOTHY J.Director | Grant | 11.6k | — | — | Jun 3, 2026 |
| MADDEN MARTIN JDirector | Grant | 11.6k | — | — | Jun 3, 2026 |
| HILLEMAN JERYL LDirector | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
| LEUNG KINYIP GABRIELDirector | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
| HUNG DAVID TDirector | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
| VERNON WILLIAM ANTHONYDirector | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
| SCANNELL TIMOTHY J.Director | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
| OCEAN ALLYSON JDirector | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
| STAFFORD KRISTINDirector | Sell | 2.9k | $15.77 | $46k | Jun 2, 2026 |
No analyst notes on NVCR yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 3 | 3 | 0 | 0 | Buy2.29 |
| 1 mo ago | 1 | 3 | 3 | 0 | 0 | Buy2.29 |
| 2 mo ago | 1 | 3 | 3 | 0 | 0 | Buy2.29 |
| 3 mo ago | 1 | 3 | 3 | 0 | 0 | Buy2.29 |
Members whose judged calls on NVCR have played out most reliably.
No settled calls on NVCR yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice